首页> 外文期刊>The Journal of Urology >Re: Lower Testosterone Levels with Luteinizing Hormone-Releasing Hormone Agonist Therapy than with Surgical Castration: New Insights Attained by Mass Spectrometry
【24h】

Re: Lower Testosterone Levels with Luteinizing Hormone-Releasing Hormone Agonist Therapy than with Surgical Castration: New Insights Attained by Mass Spectrometry

机译:回复:促黄体激素释放激素激动剂治疗的睾丸激素水平低于手术去势:质谱分析获得的新见解

获取原文
获取原文并翻译 | 示例
           

摘要

To the Editor: Can we tell from this study which option for castration (medical vs surgical) is superior for achieving lower levels of serum testosterone, or which option delivers superior clinical outcomes? This study has several important, yet not discussed, limitations.First, 20 of the 34 men in the study underwent subcapsular bilateral orchiectomy, which has the potential to leave Leydig cells and seminiferous tissue behind. How can the authors ensure that this is not a confounding factor in their analysis?
机译:致编辑:我们能否从这项研究中得知,去势(医学还是外科手术)哪个选项对降低血清睾丸激素水平比较好,或者哪个选项可以带来更好的临床效果?该研究有几个重要但尚未讨论的局限性。首先,该研究的34名男性中有20名接受了荚膜下双侧睾丸切除术,这有可能使Leydig细胞和生精组织留下。作者如何确保这不是他们分析中的混杂因素?

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号